Corvus Pharmaceuticals, Inc.
SEC Filing List
CRVS CIK: 0001626971
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 03/26/2026 | ||||
| 8-K | Current report filing | Corvus Pharmaceuticals, Inc. | Toppan Merrill/FA | 03/13/2026 | |
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | Corvus Pharmaceuticals, Inc. | Toppan Merrill/FA | 03/13/2026 | |
| S-3ASR | Automatic shelf registration statement o... | Corvus Pharmaceuticals, Inc. | Toppan Merrill/FA | 03/13/2026 | |
| 10-K | Annual report pursuant to Section 13 and... | Corvus Pharmaceuticals, Inc. | Toppan Merrill/FA | 03/12/2026 | |
| 8-K | Current report filing | Corvus Pharmaceuticals, Inc. | GLOBENEWSWIRE INC. /fa | 03/12/2026 | |
| SCHEDULE 13G/A | Toppan Merrill/FA | 02/13/2026 | |||
| SCHEDULE 13D/A | Toppan Merrill/FA | 02/05/2026 | |||
| 4 | Statement of changes in beneficial owner... | Thompson Peter A. | Allen Overy Shearman Sterling LLP /fa | 01/30/2026 | |
| SCHEDULE 13G | 01/30/2026 | ||||
| No record found. | |||||
| Load More | |||||
